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Characterization of the Burkholderia thailandensis SOS Response by
Using Whole-Transcriptome Shotgun Sequencing
Ricky L. Ulrich,a David DeShazer,d Tara A. Kenny,a Melanie P. Ulrich,b Anna Moravusova,a Timothy Opperman,c Sina Bavari,a
Terry L. Bowlin,c Donald T. Moir,c Rekha G. Panchala
Integrated Toxicology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USAa; Edison State College, Math
and Science Department, Fort Myers, Florida, USAb; Microbiotix, Inc., Worcester, Massachusetts, USAc; Bacteriology Division, USAMRIID, Fort Detrick, Maryland, USAd

The bacterial SOS response is a well-characterized regulatory network encoded by most prokaryotic bacterial species and is involved in DNA repair. In addition to nucleic acid repair, the SOS response is involved in pathogenicity, stress-induced mutagenesis, and the emergence and dissemination of antibiotic resistance. Using high-throughput sequencing technology (SOLiD RNASeq), we analyzed the Burkholderia thailandensis global SOS response to the fluoroquinolone antibiotic, ciprofloxacin (CIP),
and the DNA-damaging chemical, mitomycin C (MMC). We demonstrate that a B. thailandensis recA mutant (RU0643) is ⬃4fold more sensitive to CIP in contrast to the parental strain B. thailandensis DW503. Our RNA-Seq results show that CIP and
MMC treatment (P < 0.01) resulted in the differential expression of 344 genes in B. thailandensis and 210 genes in RU0643. Several genes associated with the SOS response were induced and include lexA, uvrA, dnaE, dinB, recX, and recA. At the genomewide level, we found an overall decrease in gene expression, especially for genes involved in amino acid and carbohydrate transport and metabolism, following both CIP and MMC exposure. Interestingly, we observed the upregulation of several genes
involved in bacterial motility and enhanced transcription of a B. thailandensis genomic island encoding a Siphoviridae bacteriophage designated E264. Using B. thailandensis plaque assays and PCR with B. mallei ATCC 23344 as the host, we demonstrate
that CIP and MMC exposure in B. thailandensis DW503 induces the transcription and translation of viable bacteriophage in a
RecA-dependent manner. This is the first report of the SOS response in Burkholderia spp. to DNA-damaging agents. We have
identified both common and unique adaptive responses of B. thailandensis to chemical stress and DNA damage.

B

urkholderia thailandensis is a Gram-negative motile rod commonly found in stagnant waters, soils, and rice paddies in the
central and northeastern areas of Thailand (1). B. thailandensis is
genetically and physiologically similar to Burkholderia pseudomallei, the etiologic agent of melioidosis (1–3). In fact, extensive chromosomal similarities exist between B. thailandensis and B. pseudomallei, with the exception of various virulence genes that are
encoded by B. pseudomallei and absent in B. thailandensis (4). The
most notable difference between B. thailandensis and B. pseudomallei is the ability to cause disease in animals and humans.
Brett et al. reported a 50% lethal dose (LD50) of ⬍10 CFU for B.
pseudomallei in a hamster model in contrast to an LD50 of ⬎106
CFU for B. thailandensis (1). Likewise, the LD50 in BALB/c mice
for B. thailandensis is ⬎109 CFU compared in contrast to an
⬃LD50 of 182 CFU for B. pseudomallei (5, 6).
Both Gram-negative and Gram-positive bacteria respond to
environmental stresses that lead to DNA damage by the induction
of the bacterial SOS response (7–9). The SOS response involves
upregulation of a number of genes that are important for DNA
repair and the regulation of cell division (10). The majority of the
genes involved in the SOS response are negatively regulated by the
LexA repressor protein, which binds to an approximately 16- to
20-mer consensus sequence upstream of the target gene (11, 12)
and is known as the LexA binding site or SOS box. The SOS response is induced when DNA damage uncouples the replicative
DNA polymerase from helicase, resulting in the formation of single-stranded DNA (ssDNA). RecA binds to ssDNA and becomes
activated by the formation of a multimeric, nucleoprotein filament. Upon ATP binding, this nucleoprotein functions as a protease that cleaves LexA, the SOS repressor protein, which leads to
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depression of the genes involved in the bacterial SOS response
(13).
In this investigation, we analyzed the global SOS response in B.
thailandensis DW503 and an isogenic recA mutant (RU0643) to
the fluoroquinolone antibiotic, ciprofloxacin (CIP), and the
DNA-damaging chemical, mitomycin C (MMC). Using optical
density readings at 600 nm (OD600) and bacterial viability counts
(plate enumerations), we demonstrate that a B. thailandensis recA
mutant (RU0643) is substantially more sensitive to CIP and
MMC. At the transcriptional level, B. thailandensis DW503 and
RU0643 respond similarly to CIP and MMC. Numerous genes
shown to be involved in the bacterial SOS response were induced
after CIP and MMC exposure. Most notable was the downregulation of protein-encoding genes involved in amino acid and carbohydrate transport and metabolism, in addition to the induction of
a B. thailandensis Siphoviridae prophage. These results identified
both common and unique adaptive responses of B. thailandensis
to chemical stress and DNA damage.
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TABLE 1 Bacterial strains, plasmids, and primers used in this study
Strain, plasmid, or primer

Description or sequence (5=–3=)a

Source or reference

Strains
Escherichia coli
SM10
TOP10
Burkholderia thailandensis
DW503
RU0643
RU01
RU0643A

Mobilizing strain; RP4 tra genes; Kmr
Used for cloning and blue-white screening

48
Invitrogen

Derived from E264; ⌬(amrR-oprA) (Kms Gms Sms); rpsL (Smr)
DW503 derivative; recA::pTSV3; Tpr
DW503 containing pBHR1; Kmr
RU0643 expressing pBHR1 containing a wild-type copy of the DW503 recA gene; Kmr

49
This study
50
This study

Plasmids
pTSV3
pCR2.1-TOPO
pCR2.1-I0643
pTSV3-I0643
pBHR1-recA

Mobilizable suicide vector derived from PGSV3; Tpr
TA cloning vector; Kmr Apr
pCR2.1-TOPO containing a 419-bp fragment from the B. thailandensis recA gene
pTSV3 containing the EcoRI insert from pCR2.1-I0643
pBHR1 containing a wild-type copy of the DW503 recA gene; Kmr

15
Invitrogen
This study
This study
This study

Primersb
I0643iF
I0643iR
I0643cF
I0643cR
BTH_I0643F
BTH_I0643R
II2217F
II2217R
GI1F
GI1R
GI13F
GI13R
GI12F
GI12R

GCAGCCGGACACGGGCGAGCAG
CGCGGAACGGCGGCGACACCTT
GCGCCGAGATCGAGCCCTTTCAC
ATCCGCACCATCCGCACTTG
GGAATTCCGATGCCTGCCTGCAACGCGGG
CGGGATCCCGCGGAGCCTTTCTTTGCTTTC
GATCCGGCCGCGAGCGACTGGTC
GACGCCGAAGAGCCCCGACACGAA
GGGAAGACATCGAATCTGGA
TTGCGAATGAACTGACGAAG
GCGGGATCGTCCTATCAGTA
CCGTACACGTTGTCGTTGTC
AGCCGGTGCTCTTCTACAAA
CATCGATCAACGCCTGAAC

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

a

Km, kanamycin; Gm, gentamicin; Sm, streptomycin; Tp, trimethoprim; Ap, ampicillin. The EcoRI and BamHI sites incorporated into the oligonucleotides for directional cloning
are indicated in boldface.
In the I0643 primers, “i” indicates internal gene primers and “c” indicates conformation primers. The BTH PCR primers were used for the directional cloning of the B.
thailandensis lexA CDS. The II2217 PCR primers were used for RT-PCR for RNA sequencing validation. The GI PCR primers were used for B. thailandensis prophage detection and
differentiation.
b

MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plasmids used in this investigation are described in Table 1. B. thailandensis
DW503, which was derived from B. thailandensis E264, is aminoglycoside
sensitive due to a mutation in the amrA gene. B. thailandensis and Escherichia coli were cultured in Luria-Bertani (LB) broth or on LB agar at 37°C.
When needed, antibiotics were added at the following concentrations: 25
g of kanamycin (Sigma, St. Louis, MO)/ml, 25 g of polymyxin B
(Sigma)/ml, and 50 g of trimethoprim (Sigma)/ml. For recombinant
clone screening, E. coli was grown on LB plates containing the appropriate
antibiotic concentrations described above with or without 50 g of X-Gal
(5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) (Sigma)/ml using
standard procedures (14).
Construction of a B. thailandensis DW503 recA mutant. For PCR
primer design, an in silico search of the B. thailandensis E264 genome was
performed using the JCVI Comprehensive Microbial Resource site (http:
//cmr.jcvi.org/tigr-scripts/CMR/CmrHomePage.cgi) to identify the recA
ortholog BTH_I0643. A 419-bp internal gene fragment within
BTH_I0643 was amplified with PCR using the primer pairs shown in
Table 1 with B. thailandensis genomic DNA purified using a Wizard DNA
purification kit (Promega, Madison, WI). PCR was performed using the
following conditions: one cycle at 94°C for 5 min; 30 cycles at 94°C for 30
s, 56°C for 30 s, and 72°C for 30 s; followed by a final 7-min extension at
72°C. PCRs were performed using a FailSafe kit with buffer “J” (Epicentre
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Technologies, Madison, WI) and resolved on a 0.8% agarose gel. PCRs
were cleaned by using a QIAquick PCR purification kit (Qiagen, Valencia,
CA) and subcloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA). Ligations were transformed into One Shot chemically competent E. coli
TOP10 and screened accordingly (14). E. coli recombinant clones were
confirmed using colony PCR with the primer pair I0643iF and I0643iR
listed in Table 1. Gene disruption cassettes were made by digesting
pCR2.1-TOPO containing the B. thailandensis recA internal gene amplicon (419 bp) with EcoRI (New England BioLabs, Ipswich, MA), followed
by subcloning (Fast-Link DNA ligation kit; Epicentre Technologies) into
the suicide vector pTSV3 digested with EcoRI and treated with shrimp
alkaline phosphatase (New England BioLabs). Ligations were electroporated into E. coli SM10 and mobilized into B. thailandensis DW503 using
previously described methods (15). Single crossover mutants were confirmed using the primer pair I0643cF and I0643cR, which anneal to regions on the B. thailandensis chromosome that are up and down stream of
BTH_I0643 (Table 1). The extension time for the mutant confirmation
PCR was increased to 5 min to allow for the amplification of the suicide
plasmid pTSV3. All reactions were analyzed on a 0.8% agarose gel and a
shift in amplicon size of ⬃4 kb indicates site specific plasmid integration
and gene disruption.
CIP MIC determination for B. thailandensis DW503 and RU0643. B.
thailandensis DW503 and RU0643 were grown for 18 to 24 h on an LB agar
plate at 37°C. A loopful of bacteria was resuspended in 10 ml of LB broth,
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and the OD600 was determined using a SmartSpec 3000 (Bio-Rad, Hercules, CA). Bacterial suspensions were diluted to a concentration of 106
CFU/ml (conversion factor of 5 ⫻ 108 CFU/ml per OD600 unit). In each
well of a 96-well plate, 50 l of this bacterial suspension was added to plate
wells containing LB medium with the appropriate concentrations of CIP
to obtain a final bacterial concentration of ⬃5 ⫻ 104 CFU/well. Plates
were incubated for 18 to 24 h at 37°C and MICs determined both visually
and turbidimetrically at OD600 using a Tecan Infinite M1000 plate reader
(Tecan, San Jose, CA). All MICs were determined in triplicate, and the
MIC was defined as the lowest concentration of CIP that prevented any
detectable growth. Staphylococcus aureus ATCC 29213, Pseudomonas
aeruginosa ATCC 27853, and E. coli ATCC 25922 were used as quality
control strains to ensure antibiotic efficacy.
Bacterial viability and growth rate determination after CIP and
MMC exposure. A single colony of B. thailandensis DW503 or RU0643
was used to inoculate 20-ml cultures of LB broth that were cultured at
37°C for 18 to 20 h with aeration. To 20 ml of prewarmed LB broth, 1 ml
of the overnight culture was added, followed by incubation until the cultures reached the mid-log phase (OD600 ⬃0.5). Either CIP (6.5 g/ml) or
MMC (4 g/ml) was added to the bacterial cultures at 10⫻ the MIC, and
the OD600 and cell viability were monitored at 30, 60, and 120 min. To
determine cell viability, serial dilutions of each culture were prepared, and
aliquots were plated onto LB agar plates, followed by incubation at 37°C
for 18 to 20 h.
Complementation of the recA mutation in RU0643. To restore the
SOS response in RU0643, the B. thailandensis DW503 recA coding DNA
sequence (CDS) was directionally cloned into the broad-host-range plasmid pBHR1 (16). The recA gene was PCR amplified as described above
using the primer pairs listed in Table 1. The forward primer contained an
EcoRI restriction endonuclease site, while the reverse primer contained a
BamHI site. PCRs were performed as described above using a 1-min extension time. PCR products were purified using a QIAquick nucleotide
removal kit (Qiagen), digested with EcoRI and BamHI (New England
BioLabs), and subcloned into similarly digested pBHR1. Ligations were
electroporated into E. coli SM10 and mobilized into RU0643 according to
previously described methods (15).
CIP and MMC exposures. B. thailandensis DW503 and RU0643 were
cultured as described above for the bacterial viability and growth rate
determination methods. At mid-log phase (OD600 of ⬃0.5), CIP (6.5
g/ml) or MMC (4 g/ml) was added to the culture at concentrations
equivalent to 10⫻ the MIC. After chemical treatment for 2 h, 5 ml of each
bacterial culture was centrifuged, and cell pellets were resuspended in 1 ml
of TRIzol reagent (Invitrogen), followed by total RNA purification as
described by the manufacturer. Biological replicates were repeated three
independent times on separate days, and RNA was pooled for sequencing as previously described (17, 18). Total RNA was processed and
sequenced according to the methods described below by Cofactor
Genomics (St. Louis, MO).
Enrichment of rRNA-free transcriptome RNA and RNA fragmentation. Whole transcriptome RNA was enriched from 5 to 10 g of total
RNA by the removal of 23S and 16S rRNA using a RiboZero kit (Epicentre
Biotechnologies) according to the manufacturer’s instructions. A SOLiD
Total RNA-Seq kit (Foster City, CA) was used to construct transcriptome
RNA libraries according to the manufacturer’s instructions.
cDNA synthesis. 20 l of reverse transcription master mix containing
13 l of nuclease-free water, 4 l of 10⫻ RT buffer, 2 l of 2.5 mM dNTP
mix, and 1 l of ArrayScript reverse transcriptase was added to the ligation
reaction, followed by incubation at 42°C for 30 min. Synthesized cDNA
was purified with a Qiagen MinElute PCR purification kit and eluted in 10
l of EB buffer (10 mM Tris-HCl, pH 8.5). The purified cDNA was run on
a Novex 6% Tris-borate-EDTA– urea gel (Invitrogen) for size selection.
cDNA was excised from the gel at a size of 150 to 250 nucleotides and
divided into four pieces, and two in-gel PCRs were performed to obtain
enough material for subsequent emulsion PCR (ePCR). During this PCR,
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each library was barcoded using PCR primers containing different barcodes to allow for multiplex sequencing.
ePCR and sequencing. ePCR and emulsion break analyses were performed according to the Applied Biosystems SOLiD 4 system templated
bead preparation guide. The amplified beads were first run on a workflow
analysis (WFA) slide to determine the quality and quantity of beads,
which was followed by sequencing runs performed according to the Applied Biosystems SOLiD 4 system instrument operation guide.
Sequence alignments, clustering, and normalization. NovoalignCS
version v1.01.13 was used for all sequence alignments with the parameters “-o SAM -r all -l 30 -t 140 -e 10” (detailed aligner algorithm
specifics can be obtained from the Novocraft Technologies website).
Alignment data were used to generate clusters of reads (or patches)
which represent nonredundant genomic regions in B. thailandensis
E264
(http://cmr.jcvi.org/tigr-scripts/CMR/CmrHomePage.cgi).
Cluster boundaries were created by taking each experimental sample
into account during the cluster generation process to define the left- and
right-most end coordinates of each cluster. Multiple mapping reads are
neither thrown out nor counted as 1⫻ mapping at each of their respective
region(s); instead, they were given a fractional association if they map to
multiple genomic regions (i.e., a read that maps equally well to four
genomic regions would contribute 0.25⫻ of coverage to each location).
Linear normalization was performed by multiplying each experimental
sample locus coverage by the total reads of the lowest read-count sample
divided by the respective samples total reads. These normalized expression data were the basis for all subsequent comparisons of the experimental groups (i.e., CIP treated versus nontreated). The comparative expression approach steps through each cluster compares every possible pairing
of samples and generates a log2(A/B), in which A and B are the two normalized average coverages of each sample. Each read length was ⬃50 bp.
Differential gene expression analysis. The RNA expression was summarized at the gene level by mapping the sequencing reads to the B. thailandensis E264 chromosomes. The association between the log2 fold
change value (M) for each relevant comparison (i.e., CIP-exposed cultures versus untreated control cultures) and the average signal intensity
(A) was removed by fitting a Loess curve (MA normalization, limma package for R system [Bioconductor]). The B. thailandensis “DNA stress signature” in response to both ciprofloxacin and MMC was determined by
integrating the transcriptional response in both treatment groups. Statistical significance was obtained by a moderated analysis of variance test,
implemented in the limma package (Bioconductor), which tests whether
the response average is significantly different from zero. A moderated t
test provides the same interpretation as an ordinary t-statistic except that
the standard errors have been moderated across genes by using a simple
Bayesian model. To determine functional analysis of genes significantly
induced or repressed following drug exposure, searches were performed
using clusters of orthologous groups (COG) classification (19).
In silico searches of the B. thailandensis genome for LexA binding
sites. Promoter sequences encoded within the B. thailandensis genome
were identified by using the B. thailandensis E264 chromosomes (chromosome one [http://www.ncbi.nlm.nih.gov/nuccore/NC_007651.1] and
chromosome two [http://www.ncbi.nlm.nih.gov/nuccore/CP000085.1])
with either the Gram-negative bacteria consensus LexA binding motif
(CTGT-N8-ACAG) (20) or the P. aeruginosa CTGTATAAATATACAG
(100% conserved residues are represented in boldface) LexA box as the
query sequence. Intergenic regions shorter than 50 bases were evaluated
for operon structure using the following criteria: (i) flanking genes should
be coded in the same orientation, (ii) flanking gene expression levels
should be significantly correlated (P ⬍ 0.05 [Pearson correlation]), and
(iii) 400 bases upstream of the start codon was considered the putative
promoter region.
RT-PCR RNA sequencing validation. Template RNA used for reverse
transcription-PCR (RT-PCR) was obtained using the methods described
above for RNA sequencing. SOLiD RNA sequencing results were validated using RT-PCR with the primer pairs listed in Table 1. RT-PCR was
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FIG 1 Culture densities of B. thailandensis strains after CIP and MMC treatment. (A) OD600 readings of mid-log-phase cultures of B. thailandensis DW503 and

RU0643 treated with either CIP (6.5 g/ml) or MMC (4 g/ml). Time zero indicates the point of CIP and MMC addition. Using the cultures described in panel
A, samples for RNA sequencing were prepared at the 120-min time point. (B) Killing curves (CFU/ml) of DW503 and RU0643 over 120 min after CIP and MMC
exposure. The findings represent the results from three independent experiments performed on separate days.

performed using the Access RT-PCR System (Promega) as follows: RT of
RNA was performed at 45°C for 45 min, followed by PCR amplification
using 1 cycle at 95°C for 2 min; 30 cycles at 95°C for 30 s, 56°C for 30 s,
72°C for 30 s; followed by a final extension at 72°C for 5 min. PCR products were resolved on a 0.8% agarose gel using standard methods. A representative gel to validate our RNA-Seq results is depicted in Fig. S2 in the
supplemental material.
Bacteriophage production and differentiation. Bacteriophage biosynthesis by B. thailandensis DW503 and RU0643 were monitored using
B. mallei ATCC 23344 as the host strain as previously described (19, 20).
Briefly, 3 ml of B. thailandensis DW503 and RU0643 were grown overnight in LB broth at 37°C with shaking (250 rpm). Antibiotic selection was
maintained in RU0643 during all bacterial propagation. Approximately 2
ml of each overnight culture was added to 60 ml of prewarmed LB broth,
and cultures were grown to an OD600 of ⬃0.5 as described above. CIP (6.5
g/ml) or MMC (4 g/ml) was added to the appropriate culture at concentrations equivalent to 10⫻ the MIC. Cultures were divided into 20-ml
aliquots and grown for an additional 2 h as described above. Each culture
(2 ml) was centrifuged, and the supernatant was filtered using Millex HV
0.45-m-pore-size filters (Millipore, Billerica, MA). Filtered supernatants
were serially diluted in suspension medium (SM) (21), and 100 l of the
bacteriophage filtrate and 100 l of a saturated B. mallei ATCC 23344 culture
were mixed. The phage and bacterial suspension was incubated at 25°C for 20
min and then added to 4.8 ml of molten LB top agar (0.7%) containing 4%
glycerol, and the PFU count was determined after 24 h at 37°C.
For bacteriophage differentiation, we used plaque PCR with primers
designed to amplify an internal gene amplicon within BTH_I0115 (GI1),
BTH_II1333 (GI13), and BTH_II1031 (GI12) (Table 1). A total of 10
plaques, all turbid and ca. 1 to 1.5 mm in size, from the B. thailandensis
DW503 MMC-treated cultures were picked, and bacteriophages were
eluted in 1 ml of SM for 72 h at 37°C. PCRs were performed by boiling 100
l of eluted bacteriophage and using 5 l as the template DNA. PCRs were
performed using the following conditions: one cycle at 97°C for 5 min; 30
cycles at 97°C for 30 s, 55°C for 30 s, and 72°C for 1 min; followed by a final
7-min extension at 72°C. PCRs were performed using the Epicentre FailSafe kit with buffer “D” (Epicentre Technologies) and resolved on a 2%
agarose gel.

RESULTS AND DISCUSSION

Bacterial treatment with MMC and CIP. To determine whether
the B. thailandensis SOS response is functional, we compared the
sensitivity of the B. thailandensis DW503 and the SOS-defective
recA mutant RU0643 to either CIP or MMC. The MIC values for
CIP against B. thailandensis DW503 and RU0643 were 2.5 and 0.6
g/ml, respectively, indicating the B. thailandensis SOS regulon is
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involved in the response to DNA damage produced by CIP (see
Fig. S1 in the supplemental material). The growth and killing kinetics of cultures of B. thailandensis DW503 and RU0643 exposed
to 10⫻ the MIC of MMC and CIP were monitored by measuring
the OD600 and bacterial CFU at 30, 60, and 120 min (Fig. 1).
Untreated-culture densities for both B. thailandensis DW503 and
RU0643 showed a time-dependent increase in bacterial growth
over the 2-h exposure period (Fig. 1A). No significant effect on
growth in the absence of MMC or CIP was observed for RU0643
compared to B. thailandensis DW503 (Fig. 1A). In contrast, a notable reduction in cell density was observed for RU0643 after
MMC or CIP treatment, in particular at the 120-min time point
(Fig. 1A). Likewise, a decrease in the OD600 for B. thailandensis
DW503 in response to both MMC and CIP was observed but was
not as pronounced as the response of RU0643, which demonstrates that disruption of the B. thailandensis SOS network enhances MMC and CIP sensitivity (Fig. 1A). As expected, analyses
of the killing kinetics in the presence of MMC and CIP demonstrated that both compounds reduced the CFU/ml over the 2-h
exposure period for both B. thailandensis strains characterized
(Fig. 1B). Most notable, CIP and MMC treatment of RU0643 resulted in an ⬃10-fold decrease in CFU/ml compared to B. thailandensis DW503 (Fig. 1B). Similar findings in response to CIP
exposure have been reported for E. coli in a ⌬recA background,
while a P. aeruginosa PA01 lexA mutant displayed no sensitivity to
either CIP or MMC (22, 23). These results demonstrate that the B.
thailandensis SOS response plays a role in DNA repair and responds to CIP and MMC treatment in a manner similar to that
reported for E. coli.
MMC and CIP induce the SOS response in B. thailandensis
DW503 and RU0643. To analyze the transcriptional response of
B. thailandensis DW503 and RU0643 to DNA-damaging agents,
we utilized SOLiD RNA sequencing to profile the gene expression
changes in mid-log-phase cultures of B. thailandensis DW503 and
RU0643 with or without MMC and CIP treatment. It has been
demonstrated with P. aeruginosa that over a 30- to 120-min CIP
exposure, only the magnitude of gene induction or repression
changes are different over the time course and, as a result, our
transcriptional profiling analysis only focused on the 120-min
time point (23). Using Gene Set Enrichment Analysis (GSEA)
(24), we found that the B. thailandensis global transcriptional re-
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TABLE 2 B. thailandensis DW503 and RU0643 differentially transcribed SOS genes after a 120-min exposure to CIP or MMC
Fold changea
CIP
Gene ID
BTH_I0444
BTH_I0445
BTH_I0643
BTH_I0644
BTH_I1443
BTH_I1859
BTH_I2481
BTH_II0075
a

Gene
dnaE
recA
recX
dinB
lexA
uvrA

MMC

Description

DW503

RU0643

DW503

RU0643

Conserved hypothetical protein
DNA polymerase III, alpha subunit
DNA recombination and repair
RecA regulation
Superfamily I DNA and RNA helicases
DNA polymerase IV
LexA repressor
Excinuclease ABC, subunit A

14.33
9.12
4.29
6.50
2.14
5.66
26.60
23.31

29.86
2.64
0.76
0.84
1.23
1.80
1.80
1.87

17.28
16.46
3.25
2.30
6.06
4.29
17.26
16.69

18.38
1.29
0.92
1.29
1.28
1.87
0.74
1.41

That is, the fold change in B. thailandensis DW503 and RU0643 compared to untreated controls at 120 min after CIP and MMC treatment.

sponse to MMC and CIP was very similar. To identify the RecAdependent DNA-stress signature, we identified the genes that are
differentially transcribed in response to DNA damage by combining the CIP and MMC transcriptional responses obtained from B.
thailandensis. A total of 344 genes were differentially transcribed
(DT) in B. thailandensis DW503 and 210 genes in RU0643 were
DT during CIP and MMC treatment (P ⬍ 0:01) treatment (see
Table S1 in the supplemental material). At 2 h after CIP and MMC
exposure, we observed differential transcription in several genes
known to be involved the bacterial stress response to DNA damage
(Table 2). Both CIP and MMC induced similar SOS related genes
in B. thailandensis in a RecA-dependent manner, with the most
upregulated alleles (ca. 2- to 4-fold) being involved in DNA repair
including lexA (SOS repressor protein), uvrA (excinuclease ABC
subunit A), dnaE (DNA polymerase III, alpha subunit), dinB
(DNA polymerase IV which is an SOS error-prone polymerase),
recX (regulator of RecA), and recA (DNA recombination and repair protein) (Table 2). None of the SOS-associated genes described above were significantly differentially transcribed in
RU0643, which suggests a RecA-dependent induction following
DNA damage (Table 2). As expected, these findings demonstrate
that both CIP and MMC can induce an SOS-like response in B.
thailandensis. However, the number of SOS-regulated genes that
are induced or repressed by CIP and MMC in B. thailandensis is
not as high as what has been reported for E. coli, Pseudomonas spp.,
and S. aureus (7, 8, 23, 25–29). For example, in S. aureus, CIP
induces the expression of numerous protein-encoding genes involved in DNA metabolism, including lexA and recA, in addition
to uvrA, uvrB, parE, parC, recF, gyrA, and gyrB (29). Interestingly,
in S. aureus, the expression of numerous DNA repair genes including recX, recN, xerC, xerD, and ruvB were either downregulated or unchanged in response to CIP treatment (29). In contrast,
CIP exposure of P. aeruginosa caused the repression of dnaA,
dnaN, recF, and gyrB, in addition to the downregulation of the
recG and ruvABC genes, which have been shown to be involved in
repairing DNA damage caused by CIP (23, 30, 31). However, and
similar to our findings, the latter study did report a notable induction of recA, recX, recN, and a dinB-like Y-family polymerase (23).
In B. thailandensis we observed no differential gene transcription
for the genes encoding components of the cellular replication system (i.e., dnaA, dnaN, recF, and gyrB) in addition to recG and
ruvABC, which play a role in the repair of bacterial damaged DNA
caused by CIP (31). Further, no statistically significant differences
in gene transcription were found for gyrA and gyrB, which are the
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known targets for CIP (see Table S1 in the supplemental material).
Similar findings have also been reported for Pasteurella multocida,
in which microarray analysis showed that enrofloxacin, trimethoprim, brodimoprim, and cefquinome did not alter the gene
expression profiles of their targets (32). However, our in vitro
findings using B. thailandensis DW503 and RU0643 CIP- and
MMC-treated cultures did identify the upregulation of several
Betaproteobacteria core SOS genes reported by Sanchez-Alberola
et al. (33). The latter study utilized in silico methods to predict the
SOS regulon in several Betaproteobacteria species encoding multiple chromosome genomes, including numerous Burkholderia
spp. (33). Taken together, our results suggest that different signal
types (i.e., UV versus CIP) may induce different gene sets in B.
thailandensis following DNA damage. Further, and although unclear, the B. thailandensis SOS response to DNA damage is unique
compared to other reported SOS regulons and is likely a result of
the niche in which this bacteria is adapted to survive.
Common DT gene profiles of B. thailandensis DW503 and
RU0643 following CIP and MMC treatment and comparison to
other SOS regulons. Through different mechanisms of induction,
both CIP and MIC cause DNA damage using unique pathways.
We observed both common and strain specific differential transcription patterns for B. thailandensis DW503 and RU0643 following chemical treatment. In B. thailandensis DW503, both CIP
and MIC caused a repression of several open reading frames
(ORFs; 17 common genes) encoding for proteins involved in
amino acid and carbohydrate (maltose and ribose) transport and
metabolism, primarily amino acid transporters and permeases
(Table 3 and Fig. 2A). In contrast, we observed the induction of 52
genes in B. thailandensis DW503 after CIP and MIC exposure (Fig.
2B and Table 3). A majority of these common differentially transcribed genes are located within a cluster of ORFs that encode
prophage-like proteins (Table 3). Several hypothetical proteins
were induced, along with genes involved in DNA replication,
recombination, and repair (i.e., excinuclease ABC subunit A)
(Table 3).
In RU0643, CIP and MIC treatment resulted in the downregulation of 19 common genes that are involved in various cellular
processes, mainly genes involved in secondary metabolite biosynthesis, transport, and catabolism (Fig. 2C). A majority of the common CIP and MMC repressed genes in RU0643 encode for hypothetical proteins that have undetermined function(s) (Fig. 2C and
Table 4). CIP and MIC exposure also induced 19 ORFs in RU0643
and, as observed for the downregulated genes, a majority of the
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TABLE 3 Common genes DT by B. thailandensis in response to CIP and MMC
Fold reduction (2) or
induction (1)a
Gene description

CIP

MMC

COGb

COG info

BTH_I0698
BTH_I0784
BTH_I0786
BTH_I0787
BTH_I0788
BTH_I1553
BTH_I1771
BTH_I1772
BTH_I1821
BTH_I1825
BTH_I3010
BTH_II0210
BTH_II0475
BTH_II1444
BTH_II1817
BTH_II2215
BTH_II2217

HAD-superfamily hydrolase
FscRII
Branched-chain amino acid ABC transporter
Branched-chain amino acid ABC transporter
Branched-chain amino acid ABC transporter
Maltose ABC transporter periplasmic
Amino acid ABC transporter permease
Amino acid ABC transporter permease
Histidine utilization repressor
N-Formimino-L-glutamate deiminase
Hypothetical protein
Ribose ABC transporter permease
Hypothetical protein
ABC transporter permease
Hypothetical protein
Peptide ABC transporter ATP-binding protein
Oligopeptide ABC transporter permease

2
0.08
0.16
0.11
0.06
0.09
0.10
0.14
0.06
0.13
0.11
0.10
0.06
0.16
0.14
0.08
0.03
0.04

2
0.14
0.17
0.18
0.19
0.16
0.19
0.20
0.19
0.17
0.15
0.09
0.19
0.07
0.15
0.19
0.17
0.15

R
–
E
E
E
G
E
E
K
F
–
G
–
E
–
E
E

COG0637

BTH_I0443
BTH_I0444
BTH_I0445
BTH_I1262
BTH_I1263
BTH_I1424
BTH_I1658
BTH_I2481
BTH_I2482
BTH_I2483
BTH_I3027
BTH_I3294
BTH_II0002
BTH_II0003
BTH_II0075
BTH_II0166
BTH_II1012
BTH_II1013
BTH_II1014
BTH_II1015
BTH_II1016
BTH_II1017
BTH_II1018
BTH_II1019
BTH_II1020
BTH_II1021
BTH_II1022
BTH_II1027
BTH_II1028
BTH_II1029
BTH_II1030
BTH_II1031
BTH_II1032
BTH_II1033
BTH_II1034
BTH_II1035
BTH_II1037
BTH_II1039

Hypothetical protein
Hypothetical protein
Error-prone DNA polymerase
Hypothetical protein
Hypothetical protein
EmrB/QacA family drug resistance transporter
Radical SAM domain-containing protein
LexA repressor
Hypothetical protein
Hypothetical protein
Fimbrial assembly protein PilN
Lysine-arginine-ornithine-binding periplasmic
Phage integrase
Hypothetical protein
Excinuclease ABC subunit A
Flagellar biosynthetic protein FliQ
Gp38
Gp44
Hypothetical protein
Gp41
Gp42
Bacteriophage/transposase fusion protein
Phage protein
Gp40-like protein
Gp56-like protein
Gp49
Gp50
Gp65
Mte8-like protein
Gp56
Gp57
Gp58
Gp69
Gp60
Gp72
Gp62
Gp64
Hypothetical protein

1
6.84
14.33
9.12
8.00
23.98
9.99
10.81
26.60
24.82
44.62
6.82
7.55
18.17
42.53
23.31
8.89
55.76
34.13
60.19
121.32
22.24
197.22
281.83
168.61
115.87
104.85
50.23
201.69
57.08
54.75
39.57
49.98
13.17
20.56
9.66
9.51
8.20
16.47

1
8.73
17.28
16.46
25.55
105.39
10.23
9.86
17.26
15.02
19.58
8.49
6.70
17.55
48.89
16.69
5.27
13.53
10.45
12.60
30.73
5.55
32.75
46.94
47.77
22.36
17.88
15.59
30.50
17.42
15.96
18.39
17.82
7.63
10.72
8.36
5.03
8.07
13.60

–
–
L
K
–
R
L
T
–
–
–
E
L
–
L
N
–
–
–
–
–
O
–
–
–
–
–
–
–
L
E
K
–
–
–
–
–
–

Gene ID

COG0559
COG0411
COG0410
COG1653
COG0765
COG0765
COG2188
COG0402
COG1172
COG1173
COG1124
COG1173

COG0587
COG2378
COG0477
COG1533
COG1974

COG0834
COG0582
COG0178
COG1987

COG0330

COG0863
COG0175
COG1475

(Continued on following page)
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TABLE 3 (Continued)
Fold reduction (2) or
induction (1)a
Gene ID

Gene description

CIP

MMC

COGb

BTH_II1045
BTH_II1046
BTH_II1051
BTH_II1089
BTH_II1090
BTH_II1166
BTH_II1712
BTH_II1713
BTH_II2105
BTH_II2106
BTH_II2107
BTH_II2227
BTH_II2232

Head portal protein
ClpP protease
HK97 family phage protein
Hypothetical protein
Hypothetical protein
Regulatory protein NasS
Hypothetical protein
Hypothetical protein
Hydrophobe/amphiphile efflux family protein
RND family efflux transporter MFP subunit
Hypothetical protein
CAIB/BAIF family protein
Hypothetical protein

5.70
5.27
14.70
14.89
28.74
13.20
9.68
7.86
20.40
26.18
23.43
8.08
7.28

15.54
18.51
236.67
24.00
30.81
5.36
18.34
13.71
51.77
44.88
58.80
5.23
6.85

–
O
–
–
–
P
–
S
Q
Q
I
C
O

COG info
COG0740

COG0715
COG1262
COG0841
COG0845
COG0657
COG1804
COG0298

a
2, fold reduction in gene expression relative to untreated bacterial cultures; 1, fold induction in gene expression relative to untreated bacterial cultures. CIP, ciprofloxacin;
MMC, mitomycin C.
b
COG groups: E, amino acid transport and metabolism; C, energy production and conversion; F, nucleotide transport and metabolism; G, carbohydrate transport and metabolism;
I, lipid transport and metabolism; K, transcription; L, replication, recombination, and repair; M, cell wall/membrane biogenesis; N, cell motility; O, posttranslational modification,
protein turnover, chaperones; P, inorganic ion transport and metabolism; Q, secondary metabolites biosynthesis, transport, and catabolism; R, general function prediction only; S,
function unknown; T, signal transduction mechanisms. –, not in COGs.

induced genes encode for hypothetical proteins (Table 4). However, several upregulated genes involved in amino acid transport
and metabolism, in addition to energy production and conversion, were identified as being induced (Table 4).
As observed for P. aeruginosa and S. aureus, the overall global
response of B. thailandensis DW503 and RU0643 to CIP and
MMC, was the downregulation of genes involved in essentially
every aspect of cellular homeostasis (23, 29). Unlike the findings
for P. aeruginosa and S. aureus, we observed no significant downregulation of B. thailandensis genes encoding proteins involved in
general metabolism (i.e., ATP synthases and NADH dehydrogenases), DNA metabolism (ruvA-C), cell wall biosynthesis, cell di-

FIG 2 Venn diagram of common and DT genes in B. thailandensis DW503
and RU0643 in response to CIP and MMC. (A) Genes repressed in B. thailandensis DW503; (B) genes upregulated in B. thailandensis DW503; (C) genes
downregulated in RU0643; (D) induced genes in RU0643.
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vision, efflux, and motility (Table 3; also see Table S1 in the supplemental material) (23). In B. thailandensis the most notable
genes that are repressed in response to both CIP and MMC are
amino acid transporters and permeases (Table 3 and Table S1 in
the supplemental material). Oligopeptide transport systems
(ABC) are essential for the import and export of various compounds, in particular peptide uptake and drug extrusion, and are
linked to ATP hydrolysis (34–36). The exact roles of these B. thailandensis ABC transport systems have not been characterized, but
our findings suggest that CIP and MMC exposure represses nutrient and/or substrate uptake in B. thailandensis, which is a plausible
survival strategy to environmental stress.
Cirz et al. reported the downregulation of 41 genes required for
P. aeruginosa motility in response to subinhibitory concentrations
of CIP (23). In B. thailandensis DW503, our findings demonstrate
that CIP specifically induces the upregulation of several genes involved in bacterial motility. The motility-associated protein-encoding genes that were induced are flhA (flagellar biosynthesis
protein), fliC (major structural protein component of flagellin),
fliD (flagellar hook-associated protein), fliI (flagellum-specific
ATP synthase), fliG (flagellar motor switch protein G), filF (flagellar MS-ring protein), flgD (flagellar basal body rod modification
protein), and fliN (flagellar motor switch protein) (see Table S1 in
the supplemental material). Interestingly, bacterial motility, in
particular swarming motility which requires flagella, has been directly linked to increased antibiotic resistance in both Gram-negative and -positive bacteria (37–39). Lai et al. reported that migrating swarming cells (planktonic cells) of B. thailandensis
displayed enhanced resistance to the 10 antibiotics tested in their
study, with CIP being one of the experimental compounds tested
(39). Although the B. thailandensis strain used in this investigation
is sensitive to CIP, it is conceivable that the upregulation of genes
encoding flagellum components is a defensive mechanism that
enables the bacteria to “escape” to an environment that contains
lower concentrations of the inhibitory compound.
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TABLE 4 Common genes DT by RU0643 in response to CIP and MMC
Fold reduction (2) or
induction (1)a
Description

CIP

MMC

COGb

BTH_I1985
BTH_I2201
BTH_I2343
BTH_II0368
BTH_II0442
BTH_II0455
BTH_II1224
BTH_II1225
BTH_II1226
BTH_II1227
BTH_II1229
BTH_II1232
BTH_II1233
BTH_II1242
BTH_II1245
BTH_II1246
BTH_II1267
BTH_II1372
BTH_II1648

tRNA-Ala
Molybdopterin converting factor subunit 1
ATP binding protein of ABC transporter
Hypothetical protein
Universal stress protein
Hypothetical protein
CmaB
Phosphopantetheine-containing protein
Peptide synthetase
N-Acyl homoserine lactone synthase
Sodium/hydrogen exchanger
Oligopeptidase A
Peptide synthetase
TauD/TfdA family dioxygenase
DNA-binding response regulator
Hypothetical protein
Hypothetical protein
Hypothetical protein
Hypothetical protein

2
0.16
0.04
0.13
0.06
0.15
0.08
0.13
0.17
0.10
0.07
0.13
0.12
0.13
0.16
0.01
0.02
0.03
0.13
0.02

2
0.15
0.14
0.14
0.09
0.17
0.13
0.13
0.18
0.12
0.10
0.17
0.15
0.13
0.11
0.14
0.11
0.19
0.17
0.09

–
H
G
–
T
–
–
Q
Q
–
P
E
Q
Q
T
–
–
–
–

BTH_I0072
BTH_I0444
BTH_I1020
BTH_I1722
BTH_I1917
BTH_I3294
BTH_I3328
BTH_II0165
BTH_II0166
BTH_II0178
BTH_II0324
BTH_II0417
BTH_II0533
BTH_II0896
BTH_II0979
BTH_II1605
BTH_II1631
BTH_II2049
BTH_II2121

Catalase
Hypothetical protein
Potassium-transporting ATPase, KdpF subunit-like
Lipoprotein
Hypothetical protein
Lysine-arginine-ornithine-binding periplasmic
Branched-chain amino acid ABC transporter
Flagellar biosynthetic protein FliR
Flagellar biosynthetic protein FliQ
Hypothetical protein
Sensory box histidine kinase
Bifunctional enoyl-CoA hydratase/phosphate
DGPF domain-containing protein
Aminotransferase
HAD-superfamily hydrolase
Hydrolase
Aldehyde dehydrogenase
Glyceraldehyde-3-phosphate dehydrogenase
Rieske (2Fe-2S) domain-containing protein

1
8.21
29.99
20.12
8.41
8.63
6.85
13.01
6.98
5.13
7.94
6.99
8.37
7.07
5.67
40.7
5.39
12.58
9.80
6.25

1
5.62
18.46
31.39
16.23
23.05
8.59
11.36
5.83
5.88
5.82
5.86
7.86
5.27
5.37
148.31
7.98
6.39
7.00
5.02

P
–
–
–
–
E
E
N
N
–
T
C
–
E
R
R
C
C
P

Gene ID

COG info

COG1977
COG1129
COG0589

COG1020
COG1020
COG0475
COG0339
COG1020
COG2175
COG2197

COG0753

COG0834
COG0559
COG1684
COG1987
COG0642
COG0280
COG1167
COG1011
COG3618
COG1012
COG1012
COG2146

a
2, fold reduction in gene expression relative to untreated bacterial cultures; 1, fold induction in gene expression relative to untreated bacterial cultures. CIP, ciprofloxacin;
MMC, mitomycin C.
b
COG groups: C, energy production and conversion; E, amino acid transport and metabolism; G, carbohydrate transport and metabolism; H, coenzyme transport and metabolism;
N, cell motility; P, inorganic ion transport and metabolism; Q, secondary metabolites biosynthesis, transport, and catabolism; R, general function prediction only; T, signal
transduction mechanisms. –, not in COGs.

CIP and MMC induce the transcription and biosynthesis of
B. thailandensis prophage PI E264-3. It has been well documented in the literature that DNA damage and induction of the
SOS response correlates with the lytic bacteriophage cycle (26,
40–43). B. thailandensis E264 encodes three prophage-like islands
designated PI E264-1, PI E264-2, and PI E264-3 (44). Both CIP
and MMC caused the induction of B. thailandensis DW503 putative Siphoviridae prophage PI E264-3 genes which are encoded on
genomic island 12 (Table 5) (44). We refer to PI E264-3 as E264
throughout this study. E264 is a 52-Mb prophage that is located
on B. thailandensis E264 (B. thailandensis DW503 was derived
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from B. thailandensis E264) chromosome II and is encoded within
ORFs BTH_II1011 to BTH_II1070 (44). A broad range of phage
genes were upregulated, including genes that code for head and
tail proteins, structural proteins, an integrase, ClpP protease, and
numerous glycoproteins (Table 5). A majority of the CIPand MMC-induced phage genes are clustered in close proximity
to each other on the chromosome, which suggests that their transcription could possibly result in the assembly of a mature phage.
To confirm our RNA-Seq results, we designed PCR primers for PI
E264-1, PI E264-2, and E264 and performed plaque PCR for
virus identification and differentiation. A total of 10 randomly
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TABLE 5 DT B. thailandensis prophage E264-3 genes following CIP and MMC treatment
Fold changea
CIP

MMC

Gene ID

Description

DW503

RU0643

DW503

RU0643

BTH_II1011
BTH_II1012
BTH_II1013
BTH_II1014
BTH_II1015
BTH_II1016
BTH_II1017
BTH_II1018
BTH_II1019
BTH_II1020
BTH_II1021
BTH_II1022
BTH_II1023
BTH_II1024
BTH_II1025
BTH_II1026
BTH_II1027
BTH_II1028
BTH_II1029
BTH_II1030
BTH_II1031
BTH_II1032
BTH_II1033
BTH_II1034
BTH_II1035
BTH_II1036
BTH_II1037
BTH_II1039
BTH_II1040
BTH_II1041
BTH_II1042
BTH_II1043
BTH_II1044
BTH_II1045
BTH_II1046
BTH_II1047
BTH_II1049
BTH_II1050
BTH_II1051
BTH_II1052
BTH_II1053
BTH_II1054
BTH_II1055
BTH_II1056
BTH_II1057
BTH_II1058
BTH_II1059
BTH_II1060
BTH_II1061
BTH_II1062
BTH_II1063
BTH_II1064
BTH_II1065
BTH_II1066
BTH_II1067
BTH_II1068
BTH_II1069
BTH_II1070

Integrase-like protein
Gp38
Gp44
Hypothetical protein
Gp41
Gp42
Bacteriophage/transposase fusion protein
Putative phage protein
Gp40-like protein
Gp56-like protein
Gp49
Gp50
Gp51
Gp52
Gp63
Gp64
Gp65
Mte8-like protein
Gp56
Gp57
Gp58
Gp69
Gp60
Gp72
Gp62
Gp74
Gp64
Hypothetical protein
pANL56
pANL12
59R
Conserved hypothetical phage protein
Phage terminase
Head portal protein
ClpP protease
Phage major capsid protein
Gp7
Phage head-tail adaptor
HK97 family phage protein
Gp10
Gp11
Phage tail assembly chaperone
Gp13
Gp14
Phage minor tail protein
Gp16
Phage minor tail protein L
Gp19
Bacteriophage lambda tail assembly protein I
Host specificity protein J
Gp21
Gp22
Holin
Conserved hypothetical protein
Gp23
Gp26
Gp28
MFS transporter

6.06
55.76
34.13
60.19
121.32
22.24
197.22
281.83
168.61
115.87
104.85
50.23
3.03
0.47
6.50
6.96
201.69
57.08
54.75
39.57
49.98
13.17
20.56
9.66
9.51
5.66
8.20
16.47
1.52
2.00
2.14
3.25
3.03
5.70
5.27
3.25
0.57
1.00
14.70
1.74
2.30
1.15
1.23
2.64
2.64
1.00
1.00
0.81
1.87
1.52
0.62
0.87
0.71
0.22
0.47
1.15
0.71
0.22

0.57
1.74
1.00
0.76
2.64
0.54
1.07
1.23
0.50
2.30
1.32
0.71
0.50
1.32
1.00
0.50
1.32
2.00
1.67
8.00
2.64
2.30
1.23
0.81
0.87
2.00
0.47
13.00
2.83
4.00
0.35
0.93
1.63
1.07
0.66
1.52
0.57
0.14
1.32
0.76
0.62
0.93
0.44
1.74
0.81
1.32
0.54
0.54
1.07
0.87
1.23
5.28
3.25
0.93
0.23
0.99
0.38
0.12

2.64
13.53
10.45
12.60
30.73
5.55
32.75
46.94
47.77
22.36
17.88
15.59
3.48
0.87
2.64
2.14
30.50
17.42
15.96
18.39
17.82
7.63
10.72
8.36
5.03
3.73
8.07
3.60
0.90
1.63
6.96
5.28
7.46
15.54
18.51
9.19
11.31
13.00
236.67
5.66
13.93
18.38
14.93
8.00
12.13
6.50
6.96
17.15
12.13
5.66
4.29
0.87
4.60
2.30
0.81
2.30
1.63
1.15

0.62
1.07
1.00
0.76
0.66
0.57
0.81
0.93
0.66
0.62
1.07
0.62
1.07
0.93
0.76
0.50
1.74
0.93
0.47
2.64
1.74
1.00
0.41
4.93
0.93
1.23
0.41
2.00
1.15
1.32
1.07
0.5
1.23
0.81
1.15
1.23
0.57
1.00
3.03
0.44
0.17
0.93
1.32
1.07
0.62
0.93
0.66
0.23
3.48
0.93
0.62
0.62
4.29
2.30
0.95
0.94
0.66
0.50

a

That is, the fold change compared to untreated bacterial samples. CIP, ciprofloxacin; MMC, mitomycin C.
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FIG 3 CIP and MMC cause the induction of prophage PI E264-3 in B. thailandensis DW503 in a RecA-dependent manner. (A) PFU/ml in mid-log-phase cultures
(120 min after chemical treatment) of B. thailandensis DW503 and RU0643 treated with either CIP (6.5 g/ml) or MMC (4 g/ml). (B) Prophage plaque PCR
(4 of 10 plaques analyzed) for phage identification and differentiation using the techniques described in Materials and Methods. Primer pairs were designed
specifically for PI E264-1 (GI1), PI E264-2 (GI13), and PI E264-3 (GI12) islands encoded by B. thailandensis E264 described in Table 1. Lanes: 1, M-PCR 100-bp
Low Ladder (Sigma); 2 to 4, control PCRs performed using B. thailandensis DW503 genomic DNA; 5 to 7, template DNA obtained from plaque 1; 8 to 10, plaque
DNA from prophage 2; 11 to 13, DNA from plaque 3; 14 to 16, PCR amplicons obtained using plaque 4 DNA. PCR products were separated on a 2.0% agarose
gel containing ethidium bromide.

picked plaques were analyzed from CIP- and MMC-treated B.
thailandensis DW503 cultures, and only E264 was detected (Fig.
3B). E264 produces turbid plaques ⬃1.5 mm in size on lawns of
B. mallei ATCC 23344 (data not shown). These results are consistent with the finding of Woods et al., who demonstrated that B.
thailandensis E264 produces two bacteriophages specific for B.
mallei ATCC 23344: one produced turbid plaques, and the other
produced clear plaques (19). Interestingly, the turbid-plaque-producing bacteriophage described by Woods et al. was induced
2-fold after brief UV light exposure, suggesting DNA damage is a
signal for lytic cycle conversion (19). To further couple our RNASeq and PCR results, we analyzed B. thailandensis DW503 culture
supernatants for viable bacteriophages in both untreated and
chemically exposed cells. Figure 3A shows that E264 is spontaneously produced by B. thailandensis DW503 and RU0643 at similar concentrations (⬃1.3 ⫻ 104 PFU/ml) by both strains. In contrast, exposure of B. thailandensis DW503 and RU0643 exposed to
CIP (10⫻ MIC) resulted in a notable decrease in viable E264
production, in particular for RU0643 (1.6 ⫻ 103 PFU/ml versus
2.0 ⫻ 102 PFU/ml) (Fig. 3A). However, our SOLiD RNA sequenc-
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ing results demonstrate a clear induction in the transcription of
E264 in B. thailandensis DW503 following CIP exposure (Table
5). It is plausible that the reduction in viable phage detected in B.
thailandensis culture supernatants is the result of reduced bacterial
viability after CIP treatment (Fig. 1B). The most drastic reduction
in PFU/ml formation by E264, despite E264 gene induction,
was observed in RU0643 after MMC treatment (Fig. 3A). Culture
supernatants of B. thailandensis DW503 contained 4.4 ⫻ 107 PFU
of E264/ml, whereas supernatant filtrates of RU0643 contained
1.0 ⫻ 103 PFU of E264/ml, 44,000-fold reductions in viable bacteriophage detection, respectively (Fig. 3A). Taken together, these
results demonstrate that B. thailandensis undergoes an SOS response and suggest that E264 is under regulated by a RecA-dependent repressor.
Similar results have been reported for CIP-treated cultures of
P. aeruginosa PAO1 and S. aureus 8325 in which CIP exposure
resulted in the upregulation of several prophage genes (23, 29).
Likewise, MMC treatment of Pseudomonas fluorescens strain
DC206 resulted in the upregulation of a prophage that shares homology to the B. thailandensis lambdoid phage E125 (25). How-
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FIG 4 COG categories of DT genes in B. thailandensis DW503 and RU0643 after CIP and MMC exposure. (A and B) Gene groups induced after CIP and MMC
treatment, respectively; (C and D) gene groups reduced by CIP and MMC exposure, respectively. The various COG categories are identified by capital letters as
follows: C, energy production and conversion; D, cell cycle control, mitosis, and meiosis; E, amino acid transport and metabolism; F, nucleotide transport and
metabolism; G, carbohydrate transport and metabolism; H, coenzyme transport and metabolism; I, lipid transport and metabolism; J, translation; K, transcription; L, replication; M, cell wall/membrane biogenesis; N, cell motility; O, posttranslational modification, protein turnover, chaperones; P, inorganic ion
transport and metabolism; Q, secondary metabolites biosynthesis, transport and catabolism; R, general function prediction only; S, function unknown; T, signal
transduction mechanisms; U, intracellular trafficking and secretion; V, defense mechanisms; and Y, nuclear structure. –, not in COGs.

ever, and by using plaque assays and transmission electron microscopy, the latter study was not able to detect phage particles in
culture supernatants after MMC exposure.
COG categories of B. thailandensis DW503 and RU0463 DT
genes in response to CIP and MMC. With the magnitude of the
number of DT genes, we categorized their biological roles based
on COG groups, which categorize genes based on function (45,
46). The majority of COGs identified for both strains after CIP and
MMC treatment are not in a GOG category and are likely a result
of the incomplete annotation of the B. thailandensis genome (Fig.
4). The gene induction patterns for B. thailandensis in response to
CIP and MMC vary and are more pronounced for CIP (Fig. 4A
and C). The most highly upregulated genes in B. thailandensis after
CIP exposure are in the energy production and conversion, carbohydrate transport and metabolism, lipid transport and metabolism, transcription, cell wall/membrane biogenesis, cell motility,
inorganic ion transport and metabolism, and general function
prediction groups only (Fig. 4A). Similar results were observed for
RU0643, with the exception of the cell wall/membrane biogenesis
COG group (Fig. 4A). As expected, we observed an overall reduction in gene expression for both strains to CIP and MMC, which
suggests that B. thailandensis reduces transcription and translation to compensate for drug exposure (Fig. 4C and D).
In silico analysis of the B. thailandensis genome for LexA
binding boxes. To complement our RNA sequencing results and
to identify additional genes potentially involved in the SOS response, we searched the B. thailandensis genome for LexA binding

5840

aem.asm.org

sites using the Gram-negative bacterium consensus LexA binding
motif (CTGT-N8-ACAG) (47) or the P. aeruginosa motif CTGTA
TAAATATACAG (100% conserved residues are represented in
boldface) LexA consensus sequence (23). Our search was limited
to 400 bp upstream from putative start codons, and a total of 5,265
promoters were identified and searched for LexA binding sites.
Using a 75% stringency analysis with the P. aeruginosa SOS binding site, we identified 22 putative LexA binding motifs within the
B. thailandensis genome (Table 6). Similar results were obtained
when the Gram-negative bacterial LexA binding consensus motif
was used as the query search (data not shown). We next performed a reverse search that entailed looking for putative LexA
binding sites across the whole B. thailandensis genome and then
testing whether the identified promoters are enriched among the
genes upregulated in response to CIP and MMC in a RecA-dependent fashion. The P. aeruginosa and Gram-negative SOS consensus boxes were combined, and a genome-wide search of the B.
thailandensis putative promoters was performed. We identified 11
genes whose promoters contain LexA binding sites that were upregulated in response to either CIP or MMC (Table 6). As expected, several well-characterized genes involved in the SOS response containing LexA binding motifs were identified, including
dinB (DNA polymerase IV), recA (DNA recombination and repair), and dnaE (replicative DNA polymerase) (Table 6), thus
demonstrating that our in silico search methods correlate with our
in vitro methods for gene transcription profiling. The B. thailandensis conserved SOS box logo is depicted in Fig. 5. However,
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TABLE 6 Potential LexA binding boxes in the B. thailandensis genome identified in silico and DT B. thailandensis genes in response to either CIP or
MMC found in this study
Gene IDa

Description

Gene

BTH_I0643*
BTH_I1097
BTH_I1098
BTH_I1428
BTH_I1493
BTH_I1658*
BTH_I1859*
BTH_I2480*
BTH_I2884
BTH_I2896
BTH_I2897
BTH_I3093
BTH_I3094
BTH_II0003*
BTH_II1512
BTH_II1717
BTH_II1998
BTH_II1999*
BTH_II2000
BTH_II2001
BTH_II2045
BTH_II2046

DNA recombination and repair
tRNA-Ile
tRNA-Ala
DNA-binding protein
Urease accessory protein
Radical SAM domain-containing protein
DNA polymerase IV
Sulfate ABC transporter
Hypothetical protein
tRNA-Ala
tRNA-Ile
tRNA-Ala
tRNA-Ile
Hypothetical protein
N-Acyl homoserine lactone synthase
Enoyl-coenzyme A hydratase
Hypothetical protein
Hypothetical protein
Hypothetical protein
Gp30
tRNA-Ala
tRNA-Ile

recA

Additional genesb
BTH_I0445
BTH_I1649
BTH_II0070
BTH_II0167
BTH_II0169

Error-prone DNA polymerase
Alpha/beta fold family hydrolase
Protein PalA
Flagellar biosynthesis protein
Hypothetical protein

a
b

ureG
dinB

luxR

dnaE
palA
fliP

Distance (bp)
from ATG

Sequence

89
5
117
12
227
78
9
346
248
5
5
5
5
22
64
201
242
19
244
244
5
5

CTGTTTTTTTATACAG
CTGTAAATTAGGACAG
CTGTAAATTAGGACAG
CTGGACTTTATTCCAG
CTGGGTCGAAAACCAG
CTGTATGTTTATACAG
CTGTGTTTTTGTACAG
CTGTATTTTTATACAG
CTGTCGATTTTGACAG
CTGTAAATTAGGACAG
CTGTAAATTAGGACAG
CTGTAAATTAGGACAG
CTGTAAATTAGGACAG
CTGTATATTCGTACAG
CTGTAAGGGTTAACAG
CTGTACGAATATACAG
GTGTGTATAATTACAC
GTGTGTATAATTACAC
GTGTGTAATTATACAC
GTGTGTAATTATACAC
CTGTAAATTAGGACAG
CTGTAAATTAGGACAG

88
44
160
40
40

CTGGTTCGACGGCCAG
CTTTTCATAACCAAAG
CTGTTAGATCTGACAG
CTTTGTAATGACAAAG
CTTTGTAATGACAAAG

*, DT B. thailandensis genes in response to either CIP or MMC containing a LexA binding box found in this study.
These additional genes were detected in this study following DNA damage.

LexA binding sites were also identified in promoters upstream
from genes with no known role in DNA repair and or recombination (i.e., tRNA-Ala) (Table 6). The presence of an SOS
box within the promoter region of a gene does not necessarily
mean the allele is regulated by LexA or involved in the bacterial
SOS response.
Conclusion. We characterized here the transcriptome response of B. thailandensis and a recA mutant during CIP and
MMC exposure. The two compounds had similar effects on both
cellular and metabolic pathways. We observed an overall downward trend in gene expression, in particular amino acid transporters and permeases. As anticipated, the B. thailandensis SOS response included dinB, dnaE, lexA, uvrA, and recA, which have

been identified and characterized in the SOS pathways in other
bacteria. Interestingly, we also observed the upregulation of protein encoding genes that are required for flagellum biosynthesis
and E264 production. Using plaque assays in parallel with PCR,
we showed that both CIP and MMC induce the production of
viable phage particles in B. thailandensis DW503 culture supernatants in a RecA-dependent manner. The core B. thailandensis SOS
regulon is not as large as that reported for Bacillus, E. coli, or
Pseudomonas spp. and is likely the result of the compounds utilized for SOS induction and the environmental niches that each
bacterial species occupies. Our findings provide the first comprehensive report on the characterization of a Burkholderia
SOS regulon and lay the framework for deciphering the global
effect of CIP and MMC on B. thailandensis. Given the genomic
similarity and drug resistance and sensitivity profiles between
B. thailandensis and B. pseudomallei, our findings will facilitate
rational drug design for treating disease(s) caused by infectious
Burkholderia spp.
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